RecruitingNCT06104969

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Predictive and Diagnostic Biomarkers for Diabetic Foot Ulcers: Open Wound Master Study


Sponsor

University of Michigan

Enrollment

5,000 participants

Start Date

Jun 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with diabetes, diabetic foot, and other related conditions. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(9)

University of Arizona College of Medicine

Tucson, Arizona, United States

University of Southern California

Los Angeles, California, United States

University of California - San Francisco

San Francisco, California, United States

Emory University School of Medicine

Atlanta, Georgia, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

Northwell Health

Lake Success, New York, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

University of Texas Health San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06104969


Related Trials